Related Experiment Video
Updated: May 27, 2026
07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.4K
Bladder cancer biomarkers
Dominik Godlewski1, Dorota Bartusik-Aebisher2, Sara Czech3
1Medical Center In Łańcut, 37-100 Łańcut, Poland.
Exploration of Targeted Anti-Tumor Therapy
|March 26, 2025
Summary
Novel biomarkers offer precise, sensitive, and non-invasive methods for early bladder cancer (BCa) detection, prognosis, and treatment monitoring, improving patient outcomes. These advancements aid in personalized therapy and reducing recurrence risks.
Area of Science:
- Uro-oncology
- Biomarker discovery
- Medical technology innovation
Background:
- Bladder cancer (BCa) is a common urinary tract malignancy with high recurrence rates and clinical heterogeneity.
- Traditional diagnostic methods like cystoscopy and urine cytology have limitations in sensitivity and specificity.
- There is a critical need for advanced diagnostic and prognostic tools for effective BCa management.
Purpose of the Study:
- To review recent advancements in bladder cancer biomarkers.
- To highlight the potential of biomarkers in improving early detection, prognosis, and treatment monitoring.
- To discuss the integration of biomarkers into clinical practice for personalized therapy.
Main Methods:
- A comprehensive narrative review of literature from PubMed and Web of Science.
- Inclusion of English-language articles based on titles, abstracts, and full-text availability.
- Focus on molecular, genetic, and protein biomarkers for bladder cancer.
Main Results:
- Biomarkers provide precise, sensitive, and non-invasive alternatives or complements to traditional BCa diagnostic methods.
- These biomarkers enhance understanding of BCa biology, enabling personalized treatment strategies.
- Recent advancements show transformative potential in oncological care and patient outcomes.
Conclusions:
- Biomarkers are crucial for refining diagnostic and therapeutic approaches in bladder cancer.
- Standardization, validation, and clinical integration are key challenges for biomarker implementation.
- Adoption of advanced biomarker tools promises to improve early detection, reduce recurrence, and enhance patient quality of life.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.